UK markets close in 7 hours 20 minutes
  • FTSE 100

    7,270.51
    -7.11 (-0.10%)
     
  • FTSE 250

    23,197.83
    +36.56 (+0.16%)
     
  • AIM

    1,232.10
    -1.22 (-0.10%)
     
  • GBP/EUR

    1.1852
    -0.0018 (-0.15%)
     
  • GBP/USD

    1.3754
    -0.0009 (-0.07%)
     
  • BTC-GBP

    42,441.16
    -3,383.55 (-7.38%)
     
  • CMC Crypto 200

    1,418.03
    -87.12 (-5.79%)
     
  • S&P 500

    4,574.79
    +8.31 (+0.18%)
     
  • DOW

    35,756.88
    +15.73 (+0.04%)
     
  • CRUDE OIL

    83.27
    -1.38 (-1.63%)
     
  • GOLD FUTURES

    1,788.60
    -4.80 (-0.27%)
     
  • NIKKEI 225

    29,098.24
    -7.77 (-0.03%)
     
  • HANG SENG

    25,616.05
    -422.22 (-1.62%)
     
  • DAX

    15,719.33
    -37.73 (-0.24%)
     
  • CAC 40

    6,764.24
    -2.27 (-0.03%)
     

Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

DGAP-News: CytoTools AG / Key word(s): Personnel
30.09.2021 / 16:44
The issuer is solely responsible for the content of this announcement.

Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule

- Management Board members Dr. Freyberg and Dr. Kaiser not available for contract extensions after being voted out of office by the Supervisory Board
- Management Board contracts expire by rotation today

Darmstadt, 30 September 2021 - The Supervisory Board of CytoTools AG (ISIN DE000A0KFRJ1) announces that the appointment of the two members of the Management Board of CytoTools AG, Dr. Mark-Andre Freyberg and Dr. Dirk Kaiser, will end by rotation on 30 September 2021. Following today's deselection by the Supervisory Board, both members of the Management Board are not available for a contract extension. Both members of the Management Board have therefore left the Company's Management Board today.

The Supervisory Board very much regrets that Dr. Freyberg and Dr. Kaiser are not available for a further term of office due to the current situation and expresses its respect and high appreciation for their successful work over the past 15 years. Dr. Freyberg and Dr. Kaiser will remain closely associated with the Company as founders and shareholders.

Contact:
CytoTools AG
Klappacher Str. 126
64285 Darmstadt
Phone: +49-6151-95158-12
Fax: +49-6151-95158-13
Email: kontakt@cytotools.de

About CytoTools:
CytoTools AG is a German biotechnology holding company that translates results from basic cell biology research on cell growth and programmed cell death into novel therapies for causal disease treatment and cure. CytoTools' versatile product pipeline includes proprietary chemical compounds and biopharmaceuticals that have the potential to provide new treatment options in dermatology, cardiology, urology and oncology. CytoTools is structured as a technology holding and investment company and holds interests in its subsidiaries DermaTools Biotech GmbH (65%) and CytoPharma GmbH (50%).

Disclaimer

This release contains certain forward-looking statements. These reflect the views of CytoTools as of the date of this release. Actual results achieved by CytoTools may differ materially from the findings in the forward-looking statements. CytoTools is under no obligation to update any forward-looking statements.

 


30.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

CytoTools AG

Klappacher Str. 126

64285 Darmstadt

Germany

Phone:

+49 (0)6151-951 58 12

Fax:

+49 (0)6151-951 58 13

E-mail:

kontakt@cytotools.de

Internet:

www.cytotools.de

ISIN:

DE000A0KFRJ1

WKN:

A0KFRJ

Listed:

Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange

EQS News ID:

1237234


 

End of News

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting